Company Announcements

In February, Certara, a decision-support technology and consulting organization for drug development, announced the purchase of Germany-based BaseCase Management, a data visualization SaaS company for health economic evidence. BaseCase joined Certara’s Strategic Consulting Services division.

Schrödinger, a provider of advanced molecular simulations and enterprise software solutions and services, launched in February the Schrödinger Cryo-EM Initiative (SCI) to develop breakthrough medicines leveraging cryo–electron microscopy technology and its drug discovery platform. The SCI utilizes a network of Cryo-EM centers.

ELN firm KineMatik named EOH as an authorized provider for South Africa in February.

In February, Strand Life Sciences received an investment from Quadria Capital.

LIMS company Autoscribe Informatics opened an office in Adelaide, South Australia, in February, and formed a subsidiary.

Genedata announced in February the completion of a collaboration with Boehringer Ingelheim to develop a new request management system to efficiently manage each step in the biotherapeutic protein production and QC process within R&D and simultaneously monitor all R&D operations.

In February, LIMS provider Accelerated Technology Laboratories (ATL) announced the integration of SciCloud’s ELN with its LIMS, offering a single document management solution for analytical QC, R&D studies and manufacture batch records.

Accelerated Technology Laboratories (ATL) named Steve Chase as CEO in March.

BioDiscovery partnered with Thermo Fisher Scientific in March to create an assay plus analysis cancer research package consisting of its Nexus Express for OncoScan software for Thermo Fisher’s Cancer Research portfolio. BioDiscovery initially began the OEM partnership three years ago with Affymetrix (now Thermo Fisher). The new tailored software solution offers copy number detection and downstream analysis for the OncoScan CNV Assay.

In March, Certara launched its Quantitative Systems Pharmacology (QSP) Immuno-oncology Simulator Consortium. QSP combines computational modeling and experimental methods to examine the mechanistic relationships between a drug, the biological system and the disease process. The consortium brings together leading biopharmaceutical companies in a pre-competitive environment to develop cooperatively a QSP Immuno-oncology Simulator that can model clinical populations of cancer patients. This is the company’s second QSP consortium.

Product Introductions

In February, Enamine, a chemical research organization and producer of building blocks and screening compound libraries, and medicinal chemistry software firm BioSolveIT launched the REAL Space Navigator for access to more than 640 million pharma-oriented molecules in a virtual chemical space.

In March, Enamine and ChemAxon launched an online resource to allow researchers worldwide to explore the chemical space of Enamine’s REAL database for use in virtual screening.

Certara released in February version 10 of the D360 data informatics platform for discovery scientists. It offers new visualization features, including the ability to chart chemical structures for direct structural activity display and new data-presentation capabilities.

CDD (Collaborative Drug Discovery) announced in February that its CDD Vault platform for drug discovery informatics is now also an ELN, enabling the collection of unstructured and structured data.

In February, Genedata introduced the Genedata Profiler 11.0 for automated biomarker identification for optimizing clinical trial patient selection. New features include the Clinical Subject Data Management Module, designed to integrate and process phenotypic and omic data gathered from patients in clinical drug trials.

In March, Sapio Sciences debuted the Exemplar LIMS/ELN system, which includes features to enable high levels of data representations, analysis and visualizations. The company also introduced Exemplar ELN Essentials, an SaaS solution with credit card–based, monthly billing.

elementar launched in March the ArDB software platform for the creation, management and utilization of databases of analytical results and data visualizations. Features include the ability to generate 2D and 3D plots, and perform multivariate analysis.

Sales and Orders of Note

In February, Genedata announced that Pfizer licensed its Genedata Bioprocess enterprise platform for integration with its existing Genedata Biologics platform.

In March, ELN firm LabArchives, a research data management platform with 235,000 users, announced its users have surpassed 100 million user activities.